Interferon-β protects astrocytes against tumour necrosis factor-induced apoptosis via activation of p38 mitogen-activated protein kinase

Experimental Cell Research

Volumn 314, Issue 11-12, 2008, Pages 2231-2237

  Barca, Olga ^a   Costoya, José A ^a   Señarís, Rosa M ^a   Arce, Víctor M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Astrocytes; Interferon beta; Multiple sclerosis; Survival; Tumour necrosis factor

Indexed keywords

BETA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 45049084827     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.04.005     Document Type: Article

References (51)

1. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
2. Platanias L.C., and Fish E.N. Signaling pathways activated by interferons. Exp. Hematol. 27 (1999) 1583-1592
3. Rani M.R., and Ransohoff R.M. Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J. Interferon Cytokine Res. 25 (2005) 788-798
4. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N. Engl. J. Med. 343 (2000) 938-952
5. Bayas A., and Gold D. Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatment. J. Neurol. 250 (2003) IV/3-IV/8
6. Markowitz C.E. Interferon-beta: mechanism of action and dosing issues. Neurology 68 (2007) S8-S11
7. Billiau A. Anti-inflammatory properties of Type I interferons. Antivir. Res. 7 (2006) 108-116
8. McLaurin J., Antel J.P., and Yong V.W. Immune and non-immune actions of interferon-beta-1b on primary human neural cells. Mult. Scler. 1 (1995) 10-19
9. Heine S., Ebnet J., Maysami S., and Stangel M. Effects of interferon-beta on oligodendroglial cells. J. Neuroimmunol. 177 (2006) 173-180
10. Jin S., Kawanokuchi J., Mizuno T., Wang J., Sonobe Y., Takeuchi H., and Suzumura A. Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Brain Res. 1179 (2007) 140-146
11. Kraus J., Ling A.K., Hamm S., Voigt K., Oschmann P., and Engelhardt B. Interferon-β stabilizes barrier characteristics of brain endothelial cells in vitro. Ann. Neurol. 56 (2004) 192-205
12. Biernacki K., Antel J.P., Blain M., Narayanan S., Arnold D.L., and Prat A. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis. Arch. Neurol. 62 (2005) 563-658
13. Boutros T., Croze E., and Yong V.W. Interferon-beta is a potent promoter of nerve growth factor production by astrocytes. J. Neurochem. 69 (1997) 939-946
14. Okada K., Kuroda E., Yoshida Y., Yamashita U., Suzumura A., and Tsuji S. Effects of interferon-beta on the cytokine production of astrocytes. J. Neuroimmunol. 159 (2005) 48-54
15. Garrison J.I., Berens M.E., Shapiro J.R., Treasurywala S., and Floyd-Smith G. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines. J. Neurooncol. 30 (1996) 213-223
16. Satoh J., Paty D.W., and Kim S.U. Counteracting effect of IFN-beta on IFN-gamma-induced proliferation of human astrocytes in culture. Mult. Scler. 1 (1996) 279-287
17. Malik O., Compston D.A., and Scolding N.J. Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro. J. Neuroimmunol. 15 (1998) 155-162
18. Barca O., Ferré S., Seoane M., Prieto J.M., Lema M., Señarís R., and Arce V.M. Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase. J. Neuroimmunol. 139 (2003) 155-159
19. Barca O., Seoane M., Ferré S., Prieto J.M., Lema M., Señarís R., and Arce V.M. Mechanisms of interferon β-induced survival in fetal and neonatal primary astrocytes. Neuroimmunomodulation 14 (2007) 39-45
20. Nebreda A.R., and Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25 (2000) 257-260
21. Goh K.C., Haque S.J., and Williams B.R. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18 (1999) 5601-5608
22. Uddin S., Majchrzak B., Woodson J., Arunkumar P., Alsayed Y., Pine R., Young PR., Fish EN., and Platanias LC. Activation of the p38 mitogen-activated protein kinase by type I interferons. J. Biol. Chem. 274 (1999) 30127-30131
23. Uddin S., Lekmine F., Sharma N., Majchrzak B., Mayer I., Young P.R., Bokoch G.M., Fish E.N., and Platanias L.C. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J. Biol. Chem. 275 (2000) 27634-27640
24. Stewart V.C., Giovannoni G., Land J.M., McDonald W.I., Clark J.B., and Heales S.J. Pretreatment of astrocytes with interferon-alpha/beta prevents mitochondrial respiratory chain damage. J. Neurochem. 70 (1997) 432-434
25. Guthikonda P., Baker J., and Mattson D.H. Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line. J. Neuroimmunol. 82 (1998) 133-139
26. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
27. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., and Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17 (1999) 331-367
28. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., and Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153 (1998) 801-813
29. Akassoglou K., Bauer J., Kassiotis G., Lassmann H., Kollias G., and Probert L. Transgenic models of TNF induced demyelination. Adv. Exp. Med. Biol. 468 (1999) 245-259
30. Selmaj K., Raine C.S., and Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30 (1991) 694-700
31. Kassiotis G., Bauer J., Akassoglou K., Lassmann H., Kollias G., and Probert L. A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. Eur. J. Immunol. 29 (1999) 912-917
32. Hofman F.M., Hinton D.R., Johnson K., and Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170 (1989) 607-612
33. Selmaj K., Raine C.S., Cannella B., and Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87 (1991) 949-954
34. Sharief M.K., and Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N. Engl. J. Med. 325 (1991) 467-472
35. M.P. Quinones, Y. Kalkondea, C.A. Estrada, F. Jimenez, R. Ramirez, L. Mahimainathan, S. Mummidi, G.G. Choudhury, H. Martinez, L. Adams, M. Mack, R. LReddick, S. Maffi, S. Haralambous, L. Probert, S.K. Ahuja, S.S. Ahuja, Role of astrocytes and chemokine systems in acute TNFα induced demyelinating syndrome: CCR2-dependent signals promote astrocyte activation and survival via NF-κB and Akt, Mol. Cell Neurosci. 37 (2008) 96-109.
36. Brück W., and Stadelmann C. Inflammation and degeneration in multiple sclerosis. Neurol. Sci. Suppl 5 (2003) S265-S267
37. Pierre B.A.St., Merrill J.E., and Dopp J.M. Effects of cytokines on CNS cells: glia. In: Merrill R., and Benveniste E. (Eds). Cytokines and the CNS (1996), CRC, Boca Ratón 151-168
38. Antony J.M., van Marle G., Opii W., Butterfield D.A., Mallet F., Yong V.W., Wallace J.L., Deacon R.M., Warren K., and Power C. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7 (2004) 1021-1023
39. Veglianese P., Lo Coco D., Bao Cutrona M., Magnoni R., Pennacchini D., Pozzi B., Gowing G., Julien J.P., Tortarolo M., and Bendotti C. Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS. Mol. Cell. Neurosci. 31 (2006) 218-231
40. Kitsberg D., Formstecher E., Fauquet M., Kubes M., Cordier J., Canton B., Pan G., Rolli M., Glowinski J., and Chneiweiss H. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J. Neurosci. 19 (1999) 8244-8251
41. Holley J.E., Gveric D., Newcombe J., Cuzner M.L., and Gutowski N.J. Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29 (2003) 434-444
42. Shin T.K., Lee Y.D., and Sim K.B. Embryonic intermediate filaments, nestin and vimentin, expression in the spinal cords of rats with experimental autoimmune encephalomyelitis. J. Vet. Sci. 4 (2003) 9-13
43. Moreels M., Vandenabeele F., Dumont D., Robben J., and Lambrichts I. Alpha-smooth muscle actin (alpha-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-beta1). Neuropathol. Appl. Neurobiol. (2007) [Electronic publication ahead of print].
44. Hatano E., and Brenner D.A. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G1357-G1368
45. Barca O., Costoya J.A., Señarís R.Ma., and Arce V.M. IFN-β counteracts the apoptosis induced by TNF in astrocytes through stimulation of PI-3K and MEK. In: Tabira T., Yamamura T., and Kira J. (Eds). Free Papers from the 8th International Congress of Neuroimmunology (2006) 75-78 Monduzzi Editore, Bolonia
46. Nebreda A.R., and Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25 (2000) 257-260
47. Modur V., Zimmerman G.A., Prescott S.M., and McIntyre T.M. Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J. Biol. Chem. 271 (1996) 13094-13102
48. Roulston A., Reinhard C., Amiri P., and Williams L.T. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273 (1998) 10232-10239
49. Valladares A., Alvarez A.M., Ventura J.J., Roncero C., Benito M., and Porras A. p38 mitogen-activated protein kinase mediates tumor necrosis factor-alpha-induced apoptosis in rat fetal brown adipocytes. Endocrinology 141 (2000) 4383-4395
50. Myers R.R., Sekiguchi Y., Kikuchi S., Scott B., Medicherla S., Protter A., and Campana W.M. Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp. Neurol. 184 (2003) 606-614
51. Park J.G., Yuk Y., Rhim H., Yi S.Y., and Yoo Y.S. Role of p38 MAPK in the regulation of apoptosis signaling induced by TNF-alpha in differentiated PC12 cells. J. Biochem. Mol. Biol. 35 (2002) 267-272